Navigation Links
Measuring brain atrophy in patients with mild cognitive impairment
Date:6/16/2009

Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI which measures the "memory centers" of the brain and compares them to expected size is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease. The procedure can be readily used in clinics to measure brain atrophy, and may help physicians to predict decline in MCI patients. Their study has been published in the June issue of the journal Alzheimer Disease and Associated Disorders.

"Use of this procedure is like bringing the experience of an expert neuro-radiologist to any clinic that has the right software," said James Brewer, MD, PhD, assistant professor in UC San Diego's Departments of Radiology and Neurosciences. "These fully automated and rapid methods of measuring medial temporal lobe volumes may help clinicians predict cognitive decline in their patients, and have the potential to influence how neurology is practiced."

Mild cognitive impairment (MCI) is considered a transitional stage between the forgetfulness associated with normal aging and Alzheimer's disease. Yet, many patients with MCI do not progress to Alzheimer's, and these individuals don't need treatments targeted to prevent or slow down neuro-degeneration. Therefore, objective measures are necessarily to distinguish MCI patients who will clinically decline from those who will remain stable.

"Our goal was to find neuroimaging measures of change that reflected more than merely a person's advancing age, but instead correlated tightly with how a person's cognitive status worsens over time," said co-author Michael Rafii, MD, PhD, assistant professor of neurosciences at UC San Diego. "It's too early to draw a definitive comparison, but it appears that these early changes especially shrinking of the hippocampus may offer a robust biological marker for change."

Medial temporal lobe atrophy has been associated with increased risk for conversion of MCI to Alzheimer's disease. However, until now, studies have focused only on measurements of the brain's hippocampus. The extent to which volumes of the amygdala the section of the brain associated with emotions and the nearby temporal horn could predict cognitive decline was unknown.

In addition, methods to measure these parts of the brain relied on subjective assessments of MRIs using a "tracing technique" that literally required a drawing of these portions of the brain a technique that isn't practical or possible in most clinical settings.

For more than a year, researchers at the Memory Disorders Clinic at UC San Diego Medical Center have been successfully using a fully computerized procedure that takes images from the MRI scanner and translates them into quantitative values, according to Rafii, the clinic's director. UC San Diego was the first clinic site to use this technology, which is now starting to be used in other clinical settings throughout the country.

The study looked at the fully automated volume measures of 269 MCI patients over a six-month interval. Baseline volume measurements of the hippocampus, amygdala and temporal horn were evaluated as predictors of cognitive change as measured by two commonly used instruments for screening cognitive function and dementia. Patients with smaller volumes of the hippocampus and amygdala showed more rapid clinical decline on these tests.

"These values objectively measure the hippocampus and amydala, and early data confirm previous findings that these brain areas may atrophy early in Alzheimer's disease and can offer a clinical marker for change," said Rafii. The fluid-filled temporal horn increases as the hippocampus shrinks, and these complementary measurements may correlate closely with how a patient's cognitive status worsens over time, he added.


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Tool Shows Promise for Measuring Productivity of Mid-Level Oncology Providers
2. Measuring the impact of electronic medical records
3. New criteria for measuring tumor size and progression will help ease workloads in clinical trials
4. Measuring and Demonstrating the Value of Quality Initiatives
5. Measuring medicine: How new technologies could help doctors predict patient outcomes
6. MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
7. PET Scans Best for Measuring Response to Sarcoma Treatment
8. PDSS reliable in measuring impact of sleep disorders on teens academic performance
9. Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development
10. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
11. Study says COPD testing is not measuring up
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... With over ... to walk, the demand for a sustainable product to aid in the rehabilitation process ... aid in the recovery of individuals with hemiplegia due to stroke. , Ekso Bionics ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. ... from leading advocates, associations and industry leaders such as Bioness. , As ...
(Date:5/27/2016)... ... , ... Beleza Medspa has initiated a new program to assist ... first time that Coolsculpting is being used for for more than just cosmetic purposes. ... meet the prescribed body-fat standard, measured by the circumference-based tape method. The tape-test ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 Amarantus BioScience ... on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today ... be presenting at two upcoming investor conferences: SeeThru ... Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
Breaking Medicine Technology: